Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1975 Feb;2(1):87–91. doi: 10.1111/j.1365-2125.1975.tb01691.x

Lack of effect of bumetanide on body potassium content in hypertension.

L E Murchison, P D Bewsher
PMCID: PMC1402504  PMID: 1234492

Abstract

1 Twelve patients with mild hypertension were treated with bumetanide for a six-month period. No evidence was found of hypokalaemia or decreased total exchangeable potassium in subjects with or without additional potassium supplements. 2 Bumetanide was well tolerated by all patients. It caused hyperuricaemia but no episodes of gout occurred. Minor abnormalities of liver function were noted. 3 Bumetanide did not have a sustained antihypertensive action.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J., Godfrey B. E., Hill D. M., Munro-Faure A. D., Sheldon J. A comparison of the effects of hydrochlorothiazide and of frusemide in the treatment of hypertensive patients. Q J Med. 1971 Oct;40(160):541–560. [PubMed] [Google Scholar]
  2. Asbury M. J., Gatenby P. B., O'Sullivan S., Bourke E. Bumetanide: potent new "loop" diuretic. Br Med J. 1972 Jan 22;1(5794):211–213. doi: 10.1136/bmj.1.5794.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beevers D. G., Hamilton M., Harpur J. E. The long-term treatment of hypertension with thiazide diuretics. Postgrad Med J. 1971 Oct;47(552):639–643. doi: 10.1136/pgmj.47.552.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bourke E., Asbury M. J., O'Sullivan S., Gatenby P. B. The sites of action of bumetanide in man. Eur J Pharmacol. 1973 Sep;23(3):283–289. doi: 10.1016/0014-2999(73)90096-4. [DOI] [PubMed] [Google Scholar]
  5. Davidson C. Potassium supplements and diuretics. Lancet. 1972 Oct 21;2(7782):882–882. doi: 10.1016/s0140-6736(72)92254-4. [DOI] [PubMed] [Google Scholar]
  6. Davies D. L., Lant A. F., Millard N. R., Smith A. J., Ward J. W., Wilson G. M. Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide. Clin Pharmacol Ther. 1974 Feb;15(2):141–155. doi: 10.1002/cpt1974152141. [DOI] [PubMed] [Google Scholar]
  7. Edmondson R. P., Thomas R. D., Hilton P. J., Patrick J., Jones N. F. Leucocyte electrolytes in cardiac and non-cardiac patients receiving diuretics. Lancet. 1974 Jan 5;1(7845):12–14. doi: 10.1016/s0140-6736(74)93001-3. [DOI] [PubMed] [Google Scholar]
  8. Graybiel A. L., Sode J. Diuretics, potassium depletion, and carbohydrate intolerance. Lancet. 1971 Jul 31;2(7718):265–265. doi: 10.1016/s0140-6736(71)92604-3. [DOI] [PubMed] [Google Scholar]
  9. Healy J. J., McKenna T. J., Canning B. S., Brien T. G., Duffy G. J., Muldowney F. P. Body composition changes in hypertensive subjects on long-term oral diuretic therapy. Br Med J. 1970 Mar 21;1(5698):716–719. doi: 10.1136/bmj.1.5698.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henning R., Lundvall O. Evaluation in man of bumetanide, a new diuretic agent. Eur J Clin Pharmacol. 1973 Dec;6(4):224–227. doi: 10.1007/BF00644736. [DOI] [PubMed] [Google Scholar]
  11. Olesen K. H. Body composition in heart disease. Total exchangeable electrolytes in hyponatraemic hypochloraemia. Acta Med Scand. 1968 Apr;183(4):361–367. [PubMed] [Google Scholar]
  12. Olesen K. H., Sigurd B., Steiness E., Leth A. Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure. Acta Med Scand. 1973 Jan-Feb;193(1-2):119–131. [PubMed] [Google Scholar]
  13. WILSON I. M., FREIS E. D. Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation. 1959 Dec;20:1028–1036. doi: 10.1161/01.cir.20.6.1028. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES